As diabetes-related deaths in Africa begin to approach those caused by infectious diseases like malaria, a new form of diabetes linked to malnutrition is emerging among individuals unable to access screening or care. This situation is exemplified by the case of Aminatou Mana, who received a checkup from nurse Habiba Sali at the Maroua Regional Hospital in Cameroon.

J. Michael Bishop, a prominent figure in cancer research and Nobel Prize winner, has passed away at the age of 90. He was instrumental in discovering cancer-causing genes and served as chancellor of the University of California, San Francisco from 1998 to 2009, overseeing significant institutional growth.

David Botstein, a pioneering figure in gene mapping, has passed away at the age of 83. His innovative methods for locating genes within human DNA significantly advanced the understanding of genetic diseases and contributed to the comprehensive mapping of the human genome.

Scotland has become the first nation in the UK to implement newborn screening for Spinal Muscular Atrophy (SMA), a rare genetic condition that leads to progressive muscle weakness and can significantly reduce life expectancy without treatment. This initiative aims to identify affected infants early, allowing for timely intervention and improved health outcomes.

Pfizer and Valneva have reported that their experimental Lyme disease vaccine demonstrated effectiveness in preventing the tick-borne illness during a recent clinical trial, although the findings are not yet conclusive. The companies are now seeking regulatory review for this potential breakthrough, marking the first new vaccine against Lyme disease in decades.

Recent reports indicate that actions taken by Health Secretary Robert F. Kennedy Jr. are perceived as undermining the role of the Centers for Disease Control and Prevention (C.D.C.) in public health, as voiced by many current and former employees. This sentiment reflects growing concerns about the agency's effectiveness under his leadership.

The UK Health Security Agency (UKHSA) has reported that the meningitis outbreak has passed its peak, indicating a potential decline in cases. However, health officials caution that new cases may still emerge, necessitating ongoing monitoring and vigilance.

Tomos, a young boy from Wales, is among thousands suffering from myalgic encephalomyelitis (ME), an invisible illness that has severely impacted his ability to walk and talk. His family describes the available services for those affected by ME in Wales as a “desert,” highlighting the lack of support for individuals facing this debilitating condition.

Novo Nordisk has initiated a study to evaluate the safety and tolerability of LX9851, an oral obesity drug, focusing on its physiological and biological effects as it moves through the body. This research is part of the company's ongoing efforts to expand its portfolio in the obesity treatment market.